Ocular Therap
OCUL----
Ocular Therap (OCUL)
Ocular Therapeutix, Inc., a biopharmaceutical company, engages in the development and commercialization of therapies for retinal diseases and other eye conditio...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Ocular Therap Analyst Rating
View MoreForecast & Rating
Jul 17, 2026Price forecast
$27.09214.28%
Forecast & RatingStrong buy
11analysts
- Strong buy63.64%
- Buy36.36%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- PUBT · Jul 9 at 03:05 PM
Ocular Therapeutix grants new hires options for 34,700 shares at $9.66 each
- PUBT · Jul 1 at 06:02 AM
Ocular Therapeutix to present at ASRS annual meeting
- Unusual Whales · Jun 22 at 03:08 PM
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- PUBT · Jun 22 at 03:05 PM
Ocular Therapeutix grants new SVP inducement awards of 85,000 stock options, 28,000 RSUs
- Simplywall · Jun 22 at 10:06 AM
FDA Alignment on Axpaxli and New CFO Might Change The Case For Investing In Ocular Therapeutix (OCUL)
- benzinga_article · Jun 17 at 09:55 AM
Ocular Therapeutix Maps Regulatory Strategy For Lead Drug Program
